SCHEMBL1015337

SCHEMBL1015337

COC(=O)c1cc(Cl)ccc1NC(=O)COCC(=O)NCc1cccc(-c2ccco2)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SERPINE1 P05121 3/20 0.62
UBE2I P63279 2/20 0.47
CACNA1B Q00975 2/20 0.47
APBA1 Q02410 2/20 0.47
SAE1 Q9UBE0 2/20 0.47
UBA2 Q9UBT2 2/20 0.47
LMNA P02545 2/20 0.45
THRB P10828 1/20 0.45
KDM4E B2RXH2 5/20 0.45
ALDH1A1 P00352 4/20 0.45
POLB P06746 3/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
MAPK10 P53779 1/20 0.45
MAPT P10636 3/20 0.44
PRMT6 Q96LA8 1/20 0.43
HPGD P15428 4/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
NPC1 O15118 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1015171 0.91 SERPINE1 (0.75) SERPINE1UBE2ICACNA1BAPBA1SAE1
SCHEMBL1015063 0.87 SERPINE1 (0.58) SERPINE1UBE2ICACNA1BAPBA1SAE1
SCHEMBL1016295 0.87 LCLAT1 (0.49) SERPINE1LMNATHRBKDM4EALDH1A1
SCHEMBL1015802 0.86 SERPINE1 (0.84) SERPINE1KDM4EALDH1A1POLBL3MBTL1
SCHEMBL417150 0.83 SERPINE1 (0.60) SERPINE1LMNATHRBKDM4EALDH1A1
SCHEMBL1015659 0.82 SERPINE1 (0.60) SERPINE1THRBKDM4EPOLBL3MBTL1
SCHEMBL1015851 0.82 SERPINE1 (0.58) SERPINE1LMNAKDM4EL3MBTL1MAPT
SCHEMBL1015404 0.82 SERPINE1 (0.58) SERPINE1KDM4EALDH1A1POLBL3MBTL1
SCHEMBL1017187 0.82 SERPINE1 (0.57) SERPINE1KDM4EALDH1A1POLBL3MBTL1
SCHEMBL1015852 0.82 SERPINE1 (0.57) SERPINE1LMNATHRBKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8415479-B2 Inhibitor of plasminogen activator inhibitor-1 RENASCIENCE CO., LTD. (JP) 2013-04-09 US disclosed
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 RENASCIENCE CO., LTD. (JP) 2011-05-12 US disclosed
EP-2272822-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 Renascience CO., LTD. (JP) 2011-01-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 SERPINE1, SERPINB1, SERPINC1 SERPINE1 1/4885UBE2I 2656/4885CACNA1B 4702/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.